National and Kapodistrian University of Athens
Διαφλεβική σύγκλειση περιμεμβρανωδών μεσοκοιλιακών επικοινωνιών (ΠΜΚΕ) με την συσκευή amplatzer asymmetric venticular septal defect occluder
Abstract
dc:descriptionIsolated ventricular septal defects account for approximately 30% of all forms of congenital heart disease1,2. Eighty percent of these defects are perimembranous, involving the membranous septum and the adjacent area of the muscular septum. Although the operative closure of a perimembranous ventricular septal defect (PMVSD) is a straightforward and safe procedure in the current era, it is associated with morbidity, postoperative discomfort and a sternotomy scar2,3,11. As an alternative to surgical closure, during the past 16 years, a variety of occluding devices have been used for the closure of PMVSDs, but none has gained wide acceptance12,13,15,16,19. Recently, a new Amplatzer occluder (AGA Medical Corporation, Golden Valley, Minnesota) has been used to close PMVSDs in humans with quite satisfactory early results23,24,25,26,28,29,30,31,32,33. In our study we report initial and 1-year results from 23 patients with PMVSDs who underwent attempted transcatheter closure using the Amplatzer PMVSD occluder. Patient population: From October 2001 to February 2007, a total of 25 patients entered this study. Three patients were aged < 15 months. Patients were screened by conventional transthorasic 2-dimensional and color Doppler echocardiography. The criteria for inclusion in the study were (1) a distance of ? 1-2 mm from the PMVSD from the aortic valve; (2) a left to right shunt across the defect, with left ventricular enlargement (end-diastolic dimension > 95% for age); (3) body weight ? 5 kg; and (4) a calculated pulmonary vascular resistance < 8 Wood units (Rp/Rs < 0.4). Any patient with an important malalignment of the outlet septum, overriding of the aorta or pulmonary trunk or inlet (atrioventricular canal type defects) ventricular septal defect was excluded from the study. Device and procedure: The most important property of new Amplatzer PMVSD occluder is the asymmetry of its left disk, which extends 5 mm towards the apex (with a platinum market) to lean firmly on the muscular septum and only 0.5 mm towards the aorta to avoid contact with the aortic valve. Transesophageal echocardiography and hand injections of contrast medium through the arterial catheter (pigtail) were used for the optimal guidance of the procedure. The device size (waist diameter) was selected to be 1 to 2 mm larger than the largest measured diameter of the defect, as assessed by transesophageal echocardiography. However, in the presence of a large associated septal aneurysm, a device size equal to or 1 to 2 mm larger than the left ventricular diameter of the septal aneurysm was selected. All patients underwent chest radiography, electrocardiography, 24-hour Holter electrocardiographic and complete transthorasic 2-dimensional and color Doppler echocardiographic studies at 1and 3 months after the procedure and then serially every 6 months. Results: The device was not permanently implanted in only one patient, who developed complete atrioventricular block and tricuspid regurgitation, while the pusher catheter was passing the VSD. The full recovery of atrioventricular conduction was observed 10 minutes after the removal of pusher catheter...
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karanasios, Evangelos
- Καρανάσιος, Ευάγγελος
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24221